MicroStrategy
MSTR
NVIDIA
NVDA
Adobe
ADBE
Salesforce
CRM
Apple
AAPL
US Stock MarketDetailed Quotes
RMD ResMed
- 237.270
- +5.690+2.46%
Close Dec 20 16:00 ET
- 233.230
- -4.040-1.70%
Post 20:01 ET
34.83BMarket Cap31.47P/E (TTM)
238.600High231.000Low3.06MVolume231.000Open231.580Pre Close724.65MTurnover2.10%Turnover Ratio34.29P/E (Static)146.80MShares259.92752wk High6.70P/B34.61BFloat Cap162.60152wk Low1.97Dividend TTM145.85MShs Float292.875Historical High0.83%Div YieldTTM3.28%Amplitude0.864Historical Low237.032Avg Price1Lot Size
About ResMed Company
ResMed, Inc. engages in providing digital health and cloud-connected medical devices. Its digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, chronic obstructive pulmonary disease, or COPD, and other chronic diseases. The firm operates through the Sleep and Respiratory Care and Software as a Service segments. The Sleep and Respiratory Care segment engages in the sleep and respiratory disorders sector of the medical device industry. The Software as a Service segment provides business management software as a service to out-of-hospital health providers. The company was founded by Peter C. Farrell in June 1989 and is headquartered in San Diego, CA.
Company Profile
SymbolRMD
Company NameResMed
Listing DateJun 2, 1995
Issue Price11.00
Founded1989
CEOMr. Michael J. Farrell
MarketNYSE
Employees9980
Fiscal Year Ends06-30
Address9001 Spectrum Center Boulevard
CitySan Diego
ProvinceCalifornia
CountryUnited States of America
Zip Code92123
Phone1-858-836-5000
Websitehttp://www.resmed.com
Company Executives
- Name
- Position
- Salary
- Michael J. Farrell
- Chairman of the Board and Chief Executive Officer
- 14.12M
- Kaushik Ghoshal
- Chief Commercial Officer, Software as a Service Business (SaaS)
- 3.53M
- Justin Leong
- Chief Product Officer
- 3.60M
- Brett A. Sandercock
- Chief Financial Officer and Principal Accounting Officer
- 3.23M
- Dr. Peter C. Farrell, A.M.,PhD
- Director and Chairman Emeritus
- 719.69K
- Christopher DelOrefice
- Director
- --
- Carol J. Burt
- Independent Director
- 369.97K
- Richard Sulpizio
- Independent Director
- 348.72K
- Dr. Desney Tan
- Independent Director
- 329.97K
- Ronald R. Taylor
- Lead Independent Director
- 381.22K
- Karen Drexler
- Independent Director
- 334.97K
- Dr. John Hernandez
- Independent Director
- 329.97K
- Jan De Witte
- Independent Director
- 329.97K
- Harjit Gill
- Independent Director
- 329.97K
- Michael J. Rider
- Global General Counsel and Secretary
- 2.15M
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.